Australia's largest stock trading and investment forum Australia's #1 stock forum

PAR

Click for more information

0.00%

29.0¢ paradigm biopharmaceuticals limited..

"PR appears to have shown considerable foresight to pursue to...

First 66 Last

Share
Profile

Follow
Zenox

1,216 Posts.

1375

22/09/22

10:44

Post #: 63829660
Share

Originally posted by Zenox: ↑

MSB's failure was their selection of primary endpoints. NSB's failure was the active drug ingredient. Both of which PR had no input in. PAR's failure to date is the hay fever trial, and while OA is no sure thing, there is a lot of information and data that suggests iPPS could one day be a treatment for OA.

I've been looking at the history of PAR and iPPS to try to understand how this company came about. I know PR introduced iPPS to mesoblast to use in combination with mesenchymal cells, and later used iPPS to successfully treat his own OA. But what made PR establish PAR and pursue the OA avenue? Was it use of iPPS in animal OA or information in the literature or earlier OA patents? Or was it a meeting with Peter Ghosh or benepharmachem or a combination of all?

While it's easy to connect the dots moving backwards, PR appears to have shown considerable foresight to pursue to iPPS and OA link.

Expand

"PR appears to have shown considerable foresight to pursue to iPPS and OA link"

Actually this may be a bit of an overstatement since PR would've been at MSB at the same time they were pursuing arthritis and the PPS/MPC link with Peter Ghosh as a consultant, so probably would've been easy to identify the link.

PAR Price at posting: $1.25 Sentiment: Buy Disclosure: Held
3 Upvote

1 Great analysis

Reply

Top Stories

WCN

White Cliff gears up to explore expanded Nunavut Cu-Ag-Au project in Canada

CXO

Core Lithium narrowly beats guidance on FY24 spodumene production but 1Y returns still shattered

HCH

Hot Chili sets up water company as drought racks Chile–but must also build communities a desal plant

PMT

High-grade lithium zone extended at Patriot's Corvette project, drilling grades at 5%

RXM

Rex Minerals soars 60% on $390M Indonesian buyout deal from MACH Australia

There are more pages in this discussion • 605 more messages in this thread...

First 66 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 29.0¢		Change 0.000(0.00%)		Mkt cap ! $101.4M

Open	High	Low	Value	Volume
28.5¢	29.5¢	28.5¢	$79.93K	274.7K

Buyers (Bids)

No.	Vol.	Price($)
2	12951	29.0¢

Sellers (Offers)

Price($)	Vol.	No.
30.0¢	23984	3

View Market Depth

No.	Vol.	Price($)
1	2951	0.290
2	101320	0.285
4	66071	0.280
2	95130	0.275
8	103599	0.270

Price($)	Vol.	No.
0.300	23984	3
0.305	52600	2
0.310	22870	4
0.320	127570	5
0.325	3435	3

Last trade - 16.10pm 08/07/2024 (20 minute delay)

PAR (ASX) Chart